The confluence of nanotechnology and medicine: Nanomedicine is poised to revolutionize the delivery of health care to individuals and populations in the 21st century. Every medical specialty stands to be impacted as emerging nanotechnologies propel modalities for prevention, screening, diagnosis, and treatment. Medical interventions targeting vascular disease are becoming increasingly important, given current epidemiologic trends in morbidity and mortality due to these diseases. Vascular disease is a term that encompasses a collection of pathologies that affect the vessels (arteries, veins, and lymphatics) or vasculature in the body. The purpose of this article is to highlight current and emerging nanotechnologies aimed at vascular disease. Select, clinically relevant examples are described in the categories of drugs and drug delivery, imaging, sensors, biomaterials, diagnostics, and novel therapeutics. Several promising nanomedicine applications that target vascular disease are currently under various stages of development from bench top research to clinical trials. Given the rate of investment, promising research results and progression of many products to market nanomedicine applications in the prevention, diagnosis, and treatment of vascular disease holds great promise for improving the stand of care.

1.
Vascular Disease Foundation
, “
Learn About Vascular Disease
,” http://www.vdf.org/http://www.vdf.org/
2.
Vascular Disease Foundation
, “
Disease Information
,” http://www.vdf.org/diseaseinfo/http://www.vdf.org/diseaseinfo/
3.
National Institutes of Health
, 2009, “
Morbidity & Mortality: 2009 Chart Book on Cardiovascular, Lung, and Blood Diseases
,” http://www.nhlbi.nih.gov/resources/docs/2009_ChartBook.pdfhttp://www.nhlbi.nih.gov/resources/docs/2009_ChartBook.pdf
5.
National Institute of Neurological Disorders and Stroke
, 2010, “
Stroke: Hope Through Research
,” http://www.ninds.nih.gov/disorders/stroke/detail_stroke.htm#147751105http://www.ninds.nih.gov/disorders/stroke/detail_stroke.htm#147751105
7.
National Heart Lung and Blood Institute
, 2008, “
What is Peripheral Arterial Disease?
,” Disease and Condition Index, http://www.nhlbi.nih.gov/health/dci/Diseases/pad/pad_what.htmlhttp://www.nhlbi.nih.gov/health/dci/Diseases/pad/pad_what.html
8.
Centers for Disease Control and Prevention
, “
Deep Vein Thrombosis (DVT)
,” Health Care Professionals: Data and Statistics, http://www.cdc.gov/ncbddd/dvt/hcp_data.htmhttp://www.cdc.gov/ncbddd/dvt/hcp_data.htm
9.
Kapadia
,
R. M.
,
Chow
,
W. L.
,
Tsihlis
,
D. N.
,
Ahanchi
,
S. S.
,
Eng
,
W. J.
,
Murar
,
J.
,
Martinez
,
J.
,
Popwich
,
A. D.
,
Jiang
,
Q.
,
Hrabie
,
A. J.
,
Saavedra
,
E. J.
,
Keefer
,
K. L.
,
Hulvat
,
F. J.
,
Stupp
,
I. S.
, and
Kibbe
,
R. M.
, 2008, “
Nitric Oxide and Nanotechnology: A Novel Approach to Inhibit Neointimal Hyperplasia
,”
J. Vasc. Surg.
0741-5214,
47
(
1
), pp.
173
182
.
10.
Ankola
,
D. D.
,
Viswanad
,
V.
,
Bhardwaj
,
V.
,
Ramarao
,
P.
, and
Kumar
,
R.
, 2007, “
Development of Potent Oral Nanoparticulate Formulation of Coenzyme Q10 for Treatment of Hypertension: Can the Simple Nutritional Supplements be Used as First Line Therapeutic Agents for Prophylaxis/Therapy?
,”
Eur. J. Pharm. Biopharm.
0939-6411,
67
, pp.
361
369
.
11.
Chan
,
J. M.
,
Zhang
,
L.
,
Tong
,
R.
,
Ghosh
,
D.
,
Gao
,
W.
,
Liao
,
G.
,
Yuet
,
K. P.
,
Gray
,
D.
,
Rhee
,
J. -W.
,
Cheng
,
J.
,
Golomb
,
G.
,
Libby
,
P.
,
Langer
,
R.
, and
Farokhzad
,
O. C.
, 2010, “
Spatiotemporal Controlled Delivery of Nanoparticles to Injured Vasculature
,”
Proc. Natl. Acad. Sci. U.S.A.
0027-8424,
107
(
5
), pp.
2213
2218
.
12.
Haick
,
H.
,
Hakim
,
M.
,
Patrascu
,
M.
,
Levenberg
,
M.
,
Shehada
,
N.
,
Nakhoul
,
F.
, and
Abassi
,
Z.
, 2009, “
Sniffing Chronic Renal Failure in Rat Model by an Array of Random Networks of Single-Walled Carbon Nanotubes
,”
ACS Nano
1936-0851,
3
(
5
), pp.
1258
1266
.
13.
Hashi
,
K. C.
,
Zhu
,
Y.
,
Yang
,
G.
,
Young
,
L. W.
,
Hsiao
,
S. B.
,
Wang
,
K.
,
Chu
,
B.
, and
Li
,
S.
, 2007, “
Antithrombogenic Property of Bone Marrow Mesenchymal Stem Cells in Nanofibrous Vascular Grafts
,”
Proc. Natl. Acad. Sci. U.S.A.
0027-8424,
104
(
29
), pp.
11915
11920
.
14.
Hill
,
M. A.
,
Sun
,
Z.
,
Martinex-Lemus
,
L.
, and
Meininger
,
G. A.
, 2007, “
New Technologies for Dissecting the Arteriolar Myogenic Response
,”
Trends Pharmacol. Sci.
0165-6147,
28
(
7
), pp.
308
315
.
15.
Iverson
,
N.
,
Plourde
,
N.
,
Chnari
,
E.
,
Nackman
,
G.
, and
Moghe
,
P.
, 2008, “
Convergence of Nanotechnology and Cardiovascular Medicine
,”
BioDrugs
,
22
(
1
), pp.
1
10
.
16.
Lee
,
S.
,
Ferrari
,
M.
, and
Decuzzi
,
P.
, 2009, “
Design of Bio-Mimetic Particles With Enhanced Vascular Interaction
,”
J. Biomech.
0021-9290,
42
, pp.
1885
1890
.
17.
Mahapatro
,
A.
,
Johnson
,
M. D.
,
Patel
,
N. D.
,
Feldman
,
D. M.
,
Ayon
,
A. A.
, and
Agrawal
,
M.
, 2006, “
The Use of Alkanethiol Self-Assembled Monolayers on 316L Stainless Steel for Coronary Artery Stent Nanomedicine Applications: An Oxidative and In Vitro Stability Study
,”
Nanomedicine: Nanotechnology, Biology and Medicine
,
2
, pp.
182
190
.
18.
Miller
,
D. C.
,
Thapa
,
A.
,
Haberstroh
,
K. M.
, and
Webster
,
T. J.
, 2004, “
Endothelial and Vascular Smooth Muscle Cell Function on Poly(Lactic-Co-Glycolic Acid) With Nano-Structured Surface Features
,”
Biomaterials
0142-9612,
25
, pp.
53
61
.
19.
Peters
,
D.
,
Kastantin
,
M.
,
Kotamraju
,
R. V.
,
Karmali
,
P. P.
,
Gujraty
,
K.
,
Tirrell
,
M.
, and
Ruoslahti
,
E.
, 2009, “
Targeting Atherosclerosis by Using Modular Multifunctional Micelles
,”
Proc. Natl. Acad. Sci. U.S.A.
0027-8424,
106
(
24
), pp.
9815
9819
.
20.
Radomski
,
A.
,
Jurasz
,
P.
,
Alonso-Escolano
,
D.
,
Drews
,
M.
,
Morandi
,
M.
,
Malinski
,
T.
, and
Radomski
,
M.
, 2005, “
Nanoparticle-Induced Platelet Aggregation and Vascular Thrombosis
,”
Br. J. Pharmacol.
0007-1188,
146
, pp.
882
893
.
21.
Sharma
,
R.
, and
Kwon
,
S.
, 2007, “
New Applications of Nanoparticles in Cardiovascular Imaging
,”
J. Exp. Nanosci.
1745-8080,
2
(
1–2
), pp.
115
126
.
22.
Siegel
,
G.
,
Rodríguez
,
M.
,
Sauer
,
F.
,
Abletshauser
,
C.
,
De Mey
,
C.
,
Schötz
,
K.
,
Ringstad
,
L.
,
Malmsten
,
M.
, and
Schäfer
,
P.
, 2009, “
Nanotechnologic Biosensor Ellipsometry and Biomarker Pattern Analysis in the Evaluation of Atherosclerotic Risk Profile
,”
Biosens. Bioelectron.
0956-5663,
24
, pp.
1512
1517
.
23.
Wholey
,
H. M.
,
Barbato
,
E. J.
, and
Al-Khoury
,
E. G.
, 2008, “
Treatment of Asymptomatic Carotid Disease With Stenting: Pro
,”
Semin Vasc. Surg.
0895-7967,
21
, pp.
95
99
.
24.
Serruys
,
P. W.
,
Unger
,
F.
,
Sousa
,
J. E.
,
Jatene
,
A.
,
Bonnier
,
H. J. R. M.
,
Schönberger
,
J. P. A. M.
,
Buller
,
N.
,
Bonser
,
R.
,
Van Den Brand
,
M. J. B.
,
Van Herwerden
,
L. A.
,
Morel
,
M. -A. M.
, and
Van Hout
,
B. A.
, 2001, “
Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel Disease
,”
N. Engl. J. Med.
0028-4793,
344
, pp.
1117
1124
.
25.
Fischman
,
D.
,
Leon
,
M. D.
,
Baim
,
D. S.
,
Schatz
,
R. A.
,
Savage
,
M. P.
,
Penn
,
I.
,
Detre
,
K.
,
Veltri
,
L.
,
Ricci
,
D.
, and
Nobuyoshi
,
M.
, 1994, “
A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in Treatment of Coronary Artery Disease
,”
N. Engl. J. Med.
0028-4793,
331
, pp.
496
501
.
26.
Till
,
F.
,
Aliabadi
,
D.
,
Kinn
,
J. W.
,
Kaplan
,
B.
,
Bemzuly
,
K.
, and
Safian
,
R.
, 1996, “
Real Life Stenting: A Comparison of Target Vessel Revascularization in Benestent-Stress Lesions to Non Benestent-Stress Lesions
,”
Circulation
0009-7322,
94
(
332
), pp.
I
332
.
27.
Fenton
,
S.
,
Fischman
,
D. L.
,
Savage
,
M. P.
,
Schatz
,
R. A.
,
Leon
,
M. B.
,
Baim
,
D. S.
,
King
,
S. B.
,
Heuser
,
R. R.
,
Curry
,
R. C.
, Jr.
, and
Rake
,
R. C.
, 1994, “
Long-Term Angiographic and Clinical Outcome After Implantation of Balloon Expandable Stents in Aortocoronary Saphenous Vein Grafts
,”
Am. J. Cardiol.
0002-9149,
74
, pp.
1187
1191
.
28.
Babapulle
,
M. N.
,
Joseph
,
L.
,
Bélisle
,
P.
,
Brophy
,
J. M.
, and
Eisenberg
,
M. J.
, 2004, “
A Hierarchical Bayesian Meta-Analysis of Randomised Clinical Trials of Drug Eluting Stents
,”
Lancet
0140-6736,
364
, pp.
583
591
.
29.
Wessely
,
R.
,
Hausleiter
,
J.
,
Michaelis
,
C.
,
Jaschke
,
B.
,
Vogeser
,
M.
,
Milz
,
S.
,
Behnisch
,
B.
,
Schratzenstaller
,
T.
,
Renke-Gluszko
,
M.
,
Stöver
,
M.
,
Wintermantel
,
E.
,
Kastrati
,
A.
, and
Schömig
,
A.
, 2005, “
Inhibition of Neointima Formation by a Novel Drug-Eluting Stent System That Allows for Dose-Adjustable, Multiple, and On-Site Stent Coating
,”
Arterioscler., Thromb., Vasc. Biol.
1079-5642,
25
, pp.
748
753
.
30.
Sangiorgi
,
G.
,
Arbustini
,
E.
,
Lanzarini
,
P.
,
Del Bello
,
B.
,
Maestri
,
M.
,
Gaspari
,
A.
,
Solcia
,
M.
,
Virmani
,
R.
, and
Inglese
,
L.
, 2001, “
Nonbiodegradable Expanded Polytetrafluoroethylene-Covered Stent Implantation in Porcine Peripheral Arteries: Histologic Evaluation of Vascular Wall Response Compared With Uncoated Stents
,”
Cardiovasc. Intervent Radiol.
0174-1551,
24
, pp.
260
270
.
31.
Honda
,
Y.
,
Grube
,
E.
,
De La Fuente
,
L. M.
,
Yock
,
P. G.
,
Stertzer
,
S. H.
, and
Fitzgerald
,
P. J.
, 2001, “
Novel Drug-Delivery Stent: Intravascular Ultrasound Observations From the First Human Experience With the QP2-Eluting Polymer Stent System
,”
Circulation
0009-7322,
104
, pp.
380
383
.
32.
Caves
,
J. M.
, and
Chaikof
,
E. L.
, 2006, “
The Evolving Impact of Microfabrication and Nanotechnology on Stent Design
,”
J. Vasc. Surg.
0741-5214,
44
(
6
), pp.
1363
1368
.
33.
Wong
,
A. H.
,
Waugh
,
J. M.
,
Amabile
,
P. G.
,
Yuksel
,
E.
, and
Dake
,
M. D.
, 2002, “
In Vivo Vascular Engineering: Directed Migration of Smooth Muscle Cells to Limit Neointima
,”
Tissue Eng.
1076-3279,
8
, pp.
189
199
.
34.
Langsjoen
,
H.
,
Langsjoen
,
P.
,
Langsjoen
,
P.
,
Willis
,
R.
, and
Folkers
,
K.
, 1994, “
Usefulness of Coenzyme Q10 in Clinical Cardiology: A Long Term Study
,”
Mol. Aspects Med.
0098-2997,
15
, pp.
s165
s175
.
35.
Igarashi
,
T.
,
Nakajima
,
Y.
,
Tanaka
,
M.
, and
Otake
,
S.
, 1974, “
Effect of Coenzyme Q10 on Experimental Hypertension in Rats and Dogs
,”
J. Pharmacol. Exp. Ther.
0022-3565,
189
, pp.
149
156
.
36.
Yamagami
,
T.
,
Iwamoto
,
Y.
,
Folkers
,
K.
, and
Blomqvist
,
C. G.
, 1974, “
Reduction by Coenzyme Q10 of Hypertension Induced by Deoxycorticosterone and Saline in Rats
,”
Int. J. Vitam. Nutr. Res.
0300-9831,
44
, pp.
487
496
.
37.
Langsjoen
,
P.
,
Langsjoen
,
P.
,
Willis
,
R.
, and
Folkers
,
K.
, 1994, “
Treatment of Essential Hypertension With Coenzyme Q10
,”
Mol. Aspects Med.
0098-2997,
15
, pp.
s265
s272
.
38.
Digiesi
,
V.
,
Cartini
,
F.
,
Oradei
,
A.
,
Bisi
,
G.
,
Guarino
,
G. C.
,
Brocchi
,
A.
,
Bellandi
,
F.
,
Mancini
,
M.
, and
Littaru
,
G. P.
, 1994, “
Coenzyme Q10 in Essential Hypertension
,”
Mol. Aspects Med.
0098-2997,
15
, pp.
s257
s263
.
39.
Wickline
,
S. A.
,
Neubauer
,
A. M.
,
Winter
,
P.
,
Caruthers
,
S.
, and
Lanza
,
G.
, 2006, “
Applications of Nanotechnology to Atherosclerosis, Thrombosis, and Vascular Biology
,”
Arterioscler., Thromb., Vasc. Biol.
1079-5642,
26
, pp.
435
441
.
40.
Lanza
,
G.
, and
Wickline
,
S. A.
, 2001, “
Targeted Ultrasonic Contrast Agents for Molecular Imaging and Therapy
,”
Prog. Cardiovasc. Dis.
0033-0620,
44
, pp.
13
31
.
41.
Lanza
,
G.
,
Wallce
,
K.
,
Scott
,
M.
,
Cacheris
,
W.
,
Abendschein
,
D.
,
Christy
,
D.
,
Sharkey
,
A.
,
Miller
,
J.
,
Gaffney
,
P.
, and
Wickline
,
S.
, 1996, “
A Novel Site-Targeted Ultrasonic Contrast Agent With Broad Biomedical Application
,”
Circulation
0009-7322,
95
, pp.
3334
3340
.
42.
Winter
,
P. M.
,
Morawski
,
A. M.
,
Caruthers
,
S. D.
,
Fuhrhop
,
R. W.
,
Zhang
,
H.
,
Williams
,
T. A.
,
Allen
,
J. S.
,
Lacy
,
E. K.
,
Robertson
,
J. D.
,
Lanza
,
G. M.
, and
Wickline
,
S. A.
, 2003, “
Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With αvβ3-Integrin-Targeted Nanoparticles
,”
Circulation
0009-7322,
108
, pp.
2270
2274
.
43.
Ruehm
,
S.
,
Corot
,
C.
,
Vogt
,
P.
,
Kolb
,
S.
, and
Debatin
,
J.
, 2001, “
Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyper-Lipidemic Rabbits
,”
Circulation
0009-7322,
103
, pp.
415
422
.
44.
Wick
,
M. C.
,
Kremser
,
C.
,
Frischauf
,
S.
, and
Wick
,
G.
, 2008, “
In Vivo Molecular Imaging of Vascular Stress
,”
Cell Stress Chaperones
,
13
, pp.
263
273
.
45.
Garg
,
V.
, and
Hu
,
K.
, 2007, “
Protein Kinase C Isoform-Dependent Modulation of ATP-Sensitive K+Channels in Mitochondrial Inner Membrane
,”
Am. J. Physiol. Heart Circ. Physiol.
0363-6135,
293
(
3
), pp.
22
32
.
46.
Dubertret
,
B.
,
Skourides
,
P.
,
Norris
,
D. J.
,
Noireaux
,
V.
,
Brivanlou
,
A. H.
, and
Libchaber
,
A.
, 2002, “
In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles
,”
Science
0036-8075,
298
, pp.
1759
1762
.
47.
Buxton
,
D. B.
,
Lee
,
S. C.
,
Wickline
,
S. A.
, and
Ferrari
,
M.
, 2003, “
Recommendations of the National Heart Lung, and Blood Institute Nanotechnology Working Group
,”
Circulation
0009-7322,
108
, pp.
2737
2742
.
48.
Lin
,
S.
,
Lee
,
C. -K.
,
Wang
,
Y. -M.
,
Huang
,
L. -S.
,
Lin
,
Y. -H.
,
Lee
,
S. -Y.
,
Sheu
,
B. -C.
, and
Hsu
,
S. -M.
, 2006, “
Measurement of Dimensions of Pentagonal Doughnut-Shaped C-Reactive Protein Using an Atomic Force Microscope and a Dual Polarisation Interferometric Biosensor
,”
Biosens. Bioelectron.
0956-5663,
22
(
2
), pp.
323
327
.
49.
LaVan
,
D. A.
,
McGuire
,
T.
, and
Langer
,
R.
, 2003, “
Small-Scale Systems for In Vivo Drug Delivery
,”
Nat. Biotechnol.
1087-0156,
21
, pp.
1184
1191
.
50.
Cuschieri
,
A.
, 2005, “
Laparoscopic Surgery: Current Status, Issues and Future Developments
,”
Surgeon
,
3
, pp.
125
138
.
51.
Leary
,
S. P.
,
Liu
,
C. Y.
, and
Apuzzo
,
M. L. J.
, 2006, “
Toward the Emergence of Nanoneurosurgery: Part III—Nanomedicine: Targeted Nanotherapy, Nanosurgery, and Progress Toward the Realization of Nanoneurosurgery
,”
Neurosurgery
0148-396X,
58
, pp.
1009
1026
.
52.
Hede
,
S.
, and
Huilgol
,
N.
, 2006, “
‘Nano’: The New Nemesis of Cancer
,”
J. Cancer Res. Ther.
0973-1482,
2
, pp.
186
195
.
53.
Cavalcanti
,
A.
,
Shirinzadeh
,
B.
, and
Kretly
,
L. C.
, 2008, “
Medical Nanorobotics for Diabetes Control
,”
Nanomedicine: Nanotechnology, Biology and Medicine
,
4
, pp.
127
138
.
54.
Cavalcanti
,
A.
,
Shirinzadeh
,
B.
,
Freitas
,
R. A.
, Jr.
, and
Hogg
,
T.
, 2008, “
Nanorobot Architecture for Medical Target Identification
,” Available From: http://www.iop.org/EJ/abstract/0957-4484/19/015103http://www.iop.org/EJ/abstract/0957-4484/19/015103
55.
Grausova
,
L.
,
Kromka
,
A.
,
Bacakova
,
L.
,
Potocky
,
S.
,
Vanecek
,
M.
, and
Lisa
,
V.
, 2008, “
Bone and Vascular Endothelial Cells in Cultures on Nanocrystalline Diamond Films
,”
Diamond Relat. Mater.
0925-9635,
17
, pp.
1405
1409
.
56.
Ng
,
S. Y.
,
Reboud
,
J.
,
Wang
,
K. Y. P.
,
Tang
,
K. C.
,
Zhang
,
L.
,
Wong
,
P.
,
Moe
,
K. T.
,
Shim
,
W.
, and
Chen
,
Y.
, 2010, “
Label-Free Impedance Detection of Low Levels of Circulating Endothelial Progenitor Cells for Point-of-Care Diagnosis
,”
Biosens. Bioelectron.
0956-5663,
25
, pp.
1095
1101
.
57.
Culp
,
W. C.
,
Porter
,
T. R.
,
McCowan
,
T. C.
,
Roberson
,
P. K.
,
James
,
C. A.
,
Matchett
,
W. J.
, and
Moursi
,
M.
, 2003, “
Microbubble-Augmented Ultrasound Declotting of Thrombosed Arteriovenous Dialysis Grafts in Dogs
,”
J. Vasc. Interv. Radiol.
1051-0443,
14
, pp.
343
347
.
58.
Unger
,
E. C.
,
Porter
,
T.
,
Culp
,
W.
,
Labell
,
R.
,
Matsunaga
,
T.
, and
Zutshi
,
R.
, 2004, “
Therapeutic Applications of Lipid-Coated Microbubbles
,”
Adv. Drug Delivery Rev.
0169-409X,
56
(
9
), pp.
1291
1314
.
59.
Bardsley-Elliot
,
A.
, 2006, “
Biotechnology Industry Organization Annual International Convention
,”
BioDrugs
,
20
(
3
), pp.
181
190
.
60.
Unger
,
E.
, 2006, “
Treatment of Ischemic Stroke With Nanobubbles and Ultrasound
,”
J. Acoust. Soc. Am.
0001-4966,
119
(
5
), p.
3437
.
61.
Wang
,
J. Z.
,
Plourde
,
N.
, and
Iverson
,
N.
, 2007, “
Design of Nanoscale Macromolecules for Differential Display of Anionic Groups Toward Inhibition of Cellular Uptake of Oxidized Low Density Lipoproteins
,”
Int. J. Nanomedicine
,
2
(
4
),
697
705
.
You do not currently have access to this content.